Immune-based therapies such as immune checkpoint Tim3 inhibitors, BiTE immunotherapy, ADC immunotherapy, and CAR-T (Table 2) immunotherapy have been becoming therapeutic hot-researches in MM. The gene discussed is HAVCR2; the disease is Miyoshi myopathy.